Prevention of Asthma Relapse After Discharge From Emergency
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the Symbicort® Turbuhaler® to both Pulmicort®
Turbuhaler® and Bricanyl® Turbuhaler® for the treatment of asthma after discharge from the
emergency room
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Budesonide Budesonide, Formoterol Fumarate Drug Combination Formoterol Fumarate